Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.72 |
| ▸ | DGKA | P23743 | 1/20 | 0.72 |
| ▸ | HTR2C | P28335 | 1/20 | 0.67 |
| ▸ | RAD52 | P43351 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.59 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.59 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.59 |
| ▸ | FAAH | O00519 | 1/20 | 0.58 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | PAM | P19021 | 2/20 | 0.53 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9511621 | 1.00 | NAAA (0.72) | NAAADGKAHTR2CRAD52NPSR1 | |
| SCHEMBL334051 | 1.00 | NAAA (0.72) | NAAADGKAHTR2CRAD52NPSR1 | |
| SCHEMBL1091514 | 1.00 | NAAA (0.72) | NAAADGKAHTR2CRAD52NPSR1 | |
| SCHEMBL21044706 | 1.00 | NAAA (0.72) | NAAADGKAHTR2CRAD52NPSR1 | |
| SCHEMBL21044646 | 1.00 | NAAA (0.72) | NAAADGKAHTR2CRAD52NPSR1 | |
| SCHEMBL10149466 | 1.00 | NAAA (0.72) | NAAADGKAHTR2CRAD52NPSR1 | |
| SCHEMBL128168 | 1.00 | NAAA (0.72) | NAAADGKAHTR2CRAD52NPSR1 | |
| SCHEMBL2891994 | 1.00 | NAAA (0.72) | NAAADGKAHTR2CRAD52NPSR1 | |
| SCHEMBL1171560 | 1.00 | NAAA (0.72) | NAAADGKAHTR2CRAD52NPSR1 | |
| SCHEMBL963961 | 1.00 | NAAA (0.72) | NAAADGKAHTR2CRAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220185759-A1 | PROCESSES FOR PRODUCING CARBOXYLIC ACIDS | EASTMAN CHEMICAL COMPANY (US) | 2022-06-16 | — | — | US | claimed |
| CN-114096235-A | Antimicrobial compositions | 弗门尼舍有限公司 | 2022-02-25 | — | — | CN | claimed |
| EP-3947337-A1 | PROCESSES FOR PRODUCING CARBOXYLIC ACIDS | EASTMAN CHEMICAL COMPANY (US) | 2022-02-09 | — | — | EP | claimed |
| CN-113597423-A | Process for producing carboxylic acid | 伊士曼化工公司 | 2021-11-02 | — | — | CN | claimed |
| CN-110373273-B | Additive and method for removing plant wax | 中国烟草总公司郑州烟草研究院 | 2021-06-11 | — | — | CN | claimed |
| WO-2020205348-A1 | PROCESSES FOR PRODUCING CARBOXYLIC ACIDS | EASTMAN CHEMICAL COMPANY (US) | 2020-10-08 | — | — | WO | claimed |
| CN-110373273-A | A kind of the removing additive and removal methods of plant wax | 中国烟草总公司郑州烟草研究院 | 2019-10-25 | — | — | CN | claimed |
| US-20180220648-A1 | Chemical Combinations for Attracting Vespidae | Virsik, Kathleen (US) | 2018-08-09 | — | — | US | claimed |
| EP-4529924-B1 | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING CYTISINE | LTS LOHMANN THERAPIE SYSTEME AG (DE) | 2026-02-18 | — | — | EP | disclosed |
| EP-4583177-A1 | METHOD OF MANUFACTURING ELECTRODE, COMPOSITE ELECTRODE, ELECTROCHEMICAL ELEMENT, AND APPARATUS FOR MANUFACTURING ELECTRODE | Ricoh Company, Ltd. (JP) | 2025-07-09 | — | — | EP | disclosed |
| US-20250136349-A1 | CONTAINER AND METHOD FOR PRESERVING OR TRANSPORTING BIOLOGICAL MATERIALS | UNITED THERAPEUTICS CORPORATION (US) | 2025-05-01 | — | — | US | disclosed |
| WO-2025090717-A1 | CONTAINER AND METHOD FOR PRESERVING OR TRANSPORTING BIOLOGICAL MATERIALS | UNITED THERAPEUTICS CORPORATION (US) | 2025-05-01 | — | — | WO | disclosed |
| WO-2025068549-A1 | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING CYTISINE | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 2025-04-03 | — | — | WO | disclosed |
| EP-4529924-A1 | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING CYTISINE | LTS Lohmann Therapie-Systeme AG (DE) | 2025-04-02 | — | — | EP | disclosed |
| WO-1990008127-A1 | PROCESS AND APPARATUS | DAVY MCKEE (LONDON) LIMITED (GB) | 1990-07-26 | — | — | WO | disclosed |
| EP-0328158-A1 | A method for improving the release of a cast concrete item from the mould by applying to the mould a mould release composition | CASTROL A/S (DK) | 1989-08-16 | — | — | EP | disclosed |
| EP-0180630-A1 | A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD. | KOEGE KEMISK VAERK (DK) | 1986-05-14 | — | — | EP | disclosed |
| WO-1985005066-A1 | A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD | KEMISK VA^ERK KO^/GE A/S (DK) | 1985-11-21 | — | — | WO | disclosed |
| US-4112235-A | Transesterification of carboxylic acids | UOP INC. (US) | 1978-09-05 | — | — | US | disclosed |
| US-4088820-A | Transesterification of olefins | UOP INC. (US) | 1978-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220185759-A1 | PROCESSES FOR PRODUCING CARBOXYLIC ACIDS | HAO2, HPD, DDO | NAAA 468/4885DGKA 198/4885HTR2C 3217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.